Roivant Sciences Ltd (ROIV)
Profitability ratios
Return on sales
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | -663.68% | -639.45% | -804.43% | -1,272.11% | -1,704.03% | -2,658.30% | -1,437.93% | -1,780.95% | -1,506.45% |
| Operating profit margin | 4,712.46% | 4,908.91% | -1,714.08% | -2,638.77% | -3,528.21% | -5,426.82% | -2,948.24% | -3,307.77% | -2,801.62% |
| Pretax margin | 4,855.92% | 5,161.57% | -1,437.69% | -2,179.96% | -3,013.45% | -5,555.75% | -3,211.46% | -2,438.21% | -1,751.26% |
| Net profit margin | 4,831.22% | 5,130.10% | -1,444.36% | -2,186.60% | -3,029.03% | -5,595.38% | -3,228.01% | -2,447.77% | -1,752.02% |
Based on the provided data, Roivant Sciences Ltd has shown volatile and concerning profitability ratios over the past few quarters. The gross profit margin has consistently been negative, indicating that the company's cost of goods sold has exceeded its revenue from sales.
However, the operating profit margin has shown significant fluctuations, with the company experiencing both positive and negative margins. This suggests that Roivant Sciences Ltd has been able to generate profits from its core operations in some periods, but has also incurred losses in others.
The pretax margin and net profit margin have also shown inconsistency, with negative margins recorded in several quarters. This indicates that after considering all expenses, including interest and taxes, the company has faced challenges in generating positive net income relative to its revenue.
Overall, the profitability ratios reflect a lack of stability and profitability for Roivant Sciences Ltd in recent quarters, highlighting the need for the company to address its cost structure and revenue generation strategies to improve its financial performance.
Return on investment
| Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 58.73% | 58.44% | -56.41% | -54.73% | -49.18% | -54.83% | -48.56% | -56.90% | -52.29% |
| Return on assets (ROA) | 60.21% | 61.08% | -47.53% | -45.35% | -42.23% | -56.54% | -53.17% | -42.10% | -32.70% |
| Return on total capital | 71.37% | 68.82% | -104.16% | -106.98% | -91.04% | -110.02% | -85.83% | -68.37% | -44.88% |
| Return on equity (ROE) | 72.86% | 73.34% | -103.50% | -106.40% | -87.15% | -130.35% | -101.50% | -79.10% | -51.01% |
Roivant Sciences Ltd's profitability ratios have shown significant fluctuations over the past few quarters.
- Operating return on assets (Operating ROA) has been positive in recent quarters, ranging from 58.44% to 58.73%, indicating the company's operational efficiency in generating profits from its assets.
- Return on assets (ROA) has also been positive, with values ranging from 42.23% to 61.08%, suggesting that the company is utilizing its assets efficiently to generate profits.
- Return on total capital has been fluctuating widely, with values ranging from -110.02% to 71.37%. The negative values in some quarters indicate that the company's total capital is not generating sufficient returns to cover its costs.
- Return on equity (ROE) has shown a similar pattern of fluctuations, ranging from -130.35% to 73.34%. The negative values suggest that the company's equity is not being efficiently utilized to generate returns for shareholders.
Overall, Roivant Sciences Ltd's profitability ratios indicate variability in its financial performance, with positive signs in terms of operating efficiency but challenges in generating returns on total capital and equity. An in-depth analysis of the company's operations and financial health would be needed to understand the underlying reasons for these fluctuations.